查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2015206

腹膜透析市場：按產品類型、治療領域、應用和最終用戶分類－2026-2032年全球市場預測

Peritoneal Dialysis Market by Product Type, Therapeutic Area, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，腹膜透析市場價值將達到 99.8 億美元，到 2026 年將成長至 103.9 億美元，到 2032 年將達到 152 億美元，複合年成長率為 6.18%。

主要市場統計數據
基準年 2025 99.8億美元
預計年份：2026年 103.9億美元
預測年份 2032 152億美元
複合年成長率 (%) 6.18%

對正在重塑臨床環境和家庭環境中腹膜透析服務的不斷發展的護理模式、技術進步和臨床重點進行基礎性概述。

腹膜透析仍然是腎臟替代療法中重要的治療方法，這主要得益於患者人群結構的變化、護理偏好的轉變以及技術的不斷進步。過去十年間，臨床醫師和醫療系統日益認知到腹膜透析在支持居家照護、縮短住院時間和提升病患自主性方面的潛力。這些變化得益於許多創新，例如週期計自動化、透析液生物相容性的提高以及遠端監測功能的整合，這些創新共同降低了門診治療的門檻。

自動化、透析液化學、遠端監測和政策獎勵方面的進步如何重新定義腹膜透析的護理模式和供應優先事項。

由於技術、醫療服務和政策等多面向因素的共同作用，腹膜透析領域正經歷著變革性的轉變。在技​​術層面，自動化已從基本的週期計功能發展到智慧系統，這些系統減少了人工操作，並透過排班、提醒和遠端資料傳輸來支援治療依從性。同時，透析液的化學性質也得到了改進，其配方能夠減輕腹膜負擔並降低併發症風險，使長期治療得以持續進行。

評估不斷變化的採購趨勢和製造商策略，以因應 2025 年關稅變化對成本、採購和服務連續性的影響。

2025年即將實施的新關稅措施將進一步加劇腹膜透析相關人員的採購和供應鏈規劃難度。進口耗材和資本設備關稅的提高，給在全球範圍內採購透析袋、連接器和週期計組件的醫療服務提供者和製造商的成本結構帶來了壓力。為因應這項挑戰，一些供應商正在加快製造地多元化，優先考慮關鍵原料的在地採購，並重新審視其供應商整合策略，以降低貿易政策變化帶來的風險。

將產品系列、治療適應症、臨床應用和最終用戶需求與策略重點連結起來的詳細細分洞察。

透過按產品、治療領域、應用和最終用戶進行細分，我們獲得了深入的洞察，揭示了整個腹膜透析生態系統中獨特的機會和挑戰。按產品類型分類，該領域涵蓋了腹膜透析液袋、引流袋、腹膜透析導管套件和傳輸器等配件，以及自動化腹膜透析週期計和持續攜帶式腹膜透析（CAPD）設備等腹膜透析設備，還有各種腹膜透析液，包括生物相容性溶液、葡萄糖溶液和低葡萄糖溶液。這些產品的差異直接影響採購週期、臨床訓練需求和資本投資決策；耗材決定了持續的物流優先事項，而醫療設備則影響臨床工作流程的重新設計。

比較區​​域支付系統、臨床實務差異和製造地如何影響全球腹膜透析市場的技術採用和普及。

區域趨勢對腹膜透析的整體情況有顯著影響，包括技術應用、監管路徑和醫療服務模式。在美洲，臨床醫生和醫療服務提供者既要努力平衡居家護理的強烈臨床需求，又要主導保險公司對「療效指標」和「成本控制」的要求，這為兼顧改善患者體驗和顯著降低住院率的價值提案創造了機會。儘管某些市場監管政策的明確性和完善的報銷機制正在加速腹膜透析的普及，但不同地區的保險公司之間仍然存在差異。

為製造商、醫療保健提供者和買家提供切實可行的策略步驟，以推動以家庭為中心的腹膜透析解決方案的韌性、臨床價值和普及。

腹膜透析產業的領導者在應對複雜的市場環境時，應採取多管齊下的策略，將產品創新、營運韌性和與支付方的合作相結合。首先，應優先開發能夠減輕臨床醫生負擔並提升患者便利性的產品，例如自動化週期計、簡化的連接系統以及膜保存解決方案。同時，應透過供應商多元化、探索關鍵零件的近岸外包以及在採購合約中納入關稅風險緩解措施來增強供應鏈韌性，從而降低政策變化帶來的風險。

我們採用穩健的混合方法，結合從業者訪談、政策分析和資料檢驗，為腹膜透析提供檢驗且可操作的見解。

支持這些發現的研究整合了質性訪談、二手文獻和比較政策分析，以確保獲得穩健且多角度驗證的見解。一手資訊來源包括與腎臟科醫生、透析護理師、採購負責人、設備工程師和保險公司代表的結構化討論，以了解臨床工作流程、採購要求和報銷考慮。二級資訊來源包括同行評審的臨床文獻、監管指導文件、產品技術規格和公共聲明，這些資料共同為臨床和商業性趨勢提供了背景資訊。

簡潔地整合策略挑戰和相關人員合作，以擴大臨床有效且運作穩健的腹膜透析計畫規模。

總之，腹膜透析正處於技術、政策和醫療服務模式的十字路口，既蘊含著巨大的機遇，也面臨營運上的挑戰。自動化和生物相容性解決方案的進步使居家治療更具可行性和臨床吸引力，但貿易政策的變化和供應鏈的脆弱性要求採取積極主動的風險緩解策略。那些能夠協調產品開發和服務模式、投資於臨床證據並採取穩健採購慣例的相關人員，將更有能力在滿足不斷成長的臨床需求的同時，保持盈利能力。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 腹膜透析市場：依產品類型分類

  • 配件
    • 腹膜透析液袋
    • 引流袋
    • 腹膜透析導管套件
    • 傳輸組
  • PD設備
    • 全自動腹膜透析週期計
    • 持續性移動腹膜透析
  • 腹膜透析液
    • 生物相容性液體
    • 葡萄糖基液體
    • 低葡萄糖溶液

第9章 腹膜透析市場：依治療區域分類

  • 急性腎損傷
  • 慢性腎臟病
  • 鬱血性心臟衰竭

第10章 腹膜透析市場：依應用領域分類

  • 糖尿病腎臟病
  • 腎絲球腎炎
  • 狼瘡性腎炎
  • 多囊腎

第11章 腹膜透析市場：依最終使用者分類

  • 透析中心
  • 居家醫療
  • 醫院

第12章 腹膜透析市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 腹膜透析市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 腹膜透析市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國腹膜透析市場

第16章：中國腹膜透析市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Advin Health Care
  • Angiplast Pvt. Ltd.
  • B. Braun Medical Ltd
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Cook Group Incorporated
  • Diaverum AB by M42
  • Fresenius Medical Care AG
  • Huaren Pharmaceutical Co., Ltd.
  • JDmeditech
  • JMS Co., Ltd.
  • Medionics International Inc.
  • Mitra Industries
  • Mozarc Medical
  • Opterion Health AG
  • PFM Medical, Inc.
  • Renax Biomedical Technology Co., Ltd.
  • Renfrew Group International
  • Romsons Prime Private limited
  • Terumo Corporation
  • Toray Industries, Inc.
  • Vivance
Product Code: MRR-030EE485159D

The Peritoneal Dialysis Market was valued at USD 9.98 billion in 2025 and is projected to grow to USD 10.39 billion in 2026, with a CAGR of 6.18%, reaching USD 15.20 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 9.98 billion
Estimated Year [2026] USD 10.39 billion
Forecast Year [2032] USD 15.20 billion
CAGR (%) 6.18%

Foundational overview of evolving care models, technology progress, and clinical priorities reshaping peritoneal dialysis delivery across clinical and home settings

Peritoneal dialysis remains a vital modality within renal replacement therapy, driven by changing patient demographics, care-delivery preferences, and continuous technological refinement. Over the past decade, clinicians and health systems have increasingly recognized the potential of peritoneal dialysis to support home-based care pathways, reduce inpatient exposure, and offer patient-centered autonomy. These shifts have been reinforced by innovations in cycler automation, improvements in solution biocompatibility, and integrated remote monitoring capabilities that together lower barriers to outpatient management.

Consequently, stakeholders from device manufacturers and solution formulators to dialysis providers and payers are reassessing clinical protocols, supply chains, and training models to align with evolving practice patterns. Clinicians emphasize preserving peritoneal membrane function and simplifying therapy regimens to improve adherence, while health systems focus on value-based outcomes and operational efficiencies. As a result, product roadmaps and strategic investments increasingly prioritize durability, connectivity, and ease of use. This introductory overview sets the foundation for a focused examination of drivers, constraints, and strategic levers that affect adoption and innovation within peritoneal dialysis moving forward.

How converging advances in automation, solution chemistry, remote monitoring, and policy incentives are redefining peritoneal dialysis care models and supply priorities

The landscape of peritoneal dialysis is undergoing transformative shifts driven by converging forces in technology, care delivery, and policy. On the technology front, automation has advanced from basic cycler functionality to intelligent systems that reduce manual steps and support adherence through scheduling, alerts, and remote data transmission. Meanwhile, solution chemistry has progressed toward formulations that reduce peritoneal membrane stress and lower complication risk, enabling longer-term therapy viability.

Simultaneously, the care-delivery paradigm is shifting toward decentralization: more patients are being managed at home with structured clinical oversight conducted remotely. This transition has catalyzed investment in telehealth-enabled monitoring, integrated supply logistics, and patient education platforms. Policy and reimbursement frameworks in several jurisdictions are adapting to incentivize home therapies, though heterogeneity remains across payers. Finally, supply chain resilience and supplier diversification have become strategic priorities after recent disruptions, prompting manufacturers to reassess sourcing, contract terms, and nearshoring options. Together, these shifts create both opportunities for differentiation and new operational challenges for manufacturers, providers, and health systems.

Assessment of evolving procurement dynamics and manufacturer strategies in response to 2025 tariff shifts that influence cost, sourcing, and service continuity

The introduction of new tariff measures in 2025 has injected additional complexity into procurement and supply chain planning for peritoneal dialysis stakeholders. Increased duties on imported consumables and capital equipment have pressured cost structures for providers and manufacturers that rely on global sourcing of bags, connectors, and cycler components. In response, some suppliers have accelerated diversification of manufacturing footprints, prioritized local sourcing of critical raw materials, and revisited supplier consolidation strategies to mitigate exposure to trade policy volatility.

These developments have also prompted health systems and purchasing groups to renegotiate long-term supply agreements, incorporate tariff contingency clauses into contracts, and evaluate total landed cost rather than unit price alone. At the same time, accelerated interest in domestic manufacturing capacities and strategic stockpiling has emerged as a buffer against future tariff-driven disruptions. Regulatory agencies and payers are increasingly attentive to how cost pressures may affect access and utilization patterns, fueling dialogue on reimbursement adjustments and value-based contracting. The net effect is a more complex procurement environment where operational agility, scenario planning, and supplier ecosystem resilience are essential to maintain continuity of peritoneal dialysis services.

Deep-dive segmentation insights connecting product portfolios, therapeutic indications, clinical applications, and end-user requirements to strategic priorities

Insights drawn from product, therapeutic, application, and end-user segmentation reveal differentiated opportunities and constraints across the peritoneal dialysis ecosystem. By product type, the space encompasses accessories-for example, bags for peritoneal dialysis solutions, drainage bags, peritoneal dialysis catheter kits, and transfer sets-alongside PD machines such as automated peritoneal dialysis cyclers and continuous ambulatory peritoneal dialysis devices, and a range of peritoneal solutions including biocompatible solutions, glucose-based solutions, and low-glucose solutions. These product distinctions directly affect procurement cycles, clinical training needs, and capital investment decisions, with consumables driving recurring logistics priorities and capital devices influencing clinical workflow redesign.

By therapeutic area, the therapy serves acute kidney injury, chronic kidney disease, and congestive heart failure populations, each with unique clinical trajectories and utilization patterns that inform device selection and solution choice. From an application perspective, managing etiologies such as diabetic nephropathy, glomerulonephritis, lupus nephritis, and polycystic kidney disease requires tailored clinical protocols and distinct monitoring strategies. End users vary from dialysis centers to home healthcare programs and hospitals, and each setting imposes different requirements for staff training, inventory management, and remote support. Integrating these segmentation lenses provides a granular view for prioritizing R&D, commercial channels, and clinical evidence generation.

Comparative view of how regional payer frameworks, clinical practice variation, and manufacturing footprints shape adoption and access across global peritoneal dialysis markets

Regional dynamics materially shape technology adoption, regulatory pathways, and care-delivery models across the peritoneal dialysis landscape. In the Americas, clinicians and providers are balancing strong clinical interest in home-based therapies with payer-driven imperatives for demonstrable outcomes and cost containment, creating fertile ground for value propositions that combine improved patient experience with measurable reductions in hospital utilization. Regulatory clarity and established reimbursement mechanisms in certain markets accelerate adoption, but disparities exist across subnational payers.

Across Europe, the Middle East & Africa, the landscape is heterogeneous: Western European markets demonstrate advanced clinical protocols and growing telehealth integration, while other territories contend with infrastructure constraints and variable access to consumables. Policymakers and health systems in the region increasingly prioritize supply chain resilience and equitable access, prompting innovative public-private partnerships. In the Asia-Pacific region, rapid growth in chronic kidney disease prevalence is intersecting with expanding healthcare infrastructure, rising demand for home therapy solutions, and active adoption of local manufacturing strategies. Diverse reimbursement regimes and workforce considerations underscore the need for region-specific commercialization and implementation plans.

Competitive dynamics in peritoneal dialysis are characterized by a mix of specialized device manufacturers, solution formulators, contract manufacturers, and emerging digital health entrants. Leading product developers continue to invest in cycler automation, sensor integration, and patient-facing applications that enable remote monitoring and adherence support. At the same time, solution innovators are focused on improving biocompatibility and reducing metabolic burden to preserve peritoneal membrane function and extend therapy longevity.

Strategic partnerships, distribution alliances, and selective acquisitions are common as established players seek to broaden portfolios and newcomers aim to scale more rapidly. Contract manufacturing and outsourcing have become important levers to manage cost and accelerate time to market, particularly where tariff dynamics or raw material constraints affect production economics. Service and support models are also evolving: companies that integrate clinical training, supply logistics, and digital follow-up can differentiate around total cost of care and patient outcomes. Finally, private equity and corporate investors remain active in the space, drawn to predictable recurring revenue from consumables and the growing clinical emphasis on home-based therapies.

Actionable strategic moves for manufacturers, providers, and purchasers to advance resilience, clinical value, and adoption of home-focused peritoneal dialysis solutions

Industry leaders seeking to navigate the complex peritoneal dialysis environment should adopt a multi-dimensional strategy that aligns product innovation with operational resilience and payer engagement. First, prioritize product development that reduces clinician burden and enhances patient usability, including cycler automation, simplified connection systems, and solutions engineered for membrane preservation. Simultaneously, strengthen supply chain resilience by diversifying supplier bases, considering nearshoring for critical components, and embedding tariff contingencies into procurement contracts to reduce exposure to policy shifts.

Equally important is to build robust clinical evidence demonstrating outcomes and cost-effectiveness tailored to key therapeutic segments and applications. Invest in pilot programs that combine remote monitoring, clinician support, and patient education to validate real-world benefits and support reimbursement discussions. Forge partnerships with payers and health systems to pilot value-based contracting models that align incentives around reduced hospitalization and enhanced quality of life. Finally, enhance commercial capabilities by developing specialized channels for home healthcare providers and by training clinical teams to support decentralized care pathways. These combined actions will position organizations to capture long-term value while protecting margins amid ongoing policy and supply-chain uncertainty.

Robust mixed-methods approach combining practitioner interviews, policy analysis, and data triangulation to deliver validated and actionable peritoneal dialysis insights

The research underpinning these insights integrates primary qualitative interviews, secondary literature synthesis, and comparative policy analysis to ensure robust, triangulated findings. Primary inputs include structured discussions with nephrologists, dialysis nurses, procurement officers, device engineers, and payer representatives to capture clinical workflows, procurement imperatives, and reimbursement considerations. Secondary sources comprised peer-reviewed clinical literature, regulatory guidance documents, technical product specifications, and public policy statements, which together contextualize clinical and commercial trends.

Data synthesis employed cross-validation techniques to reconcile divergent perspectives and identify consistent patterns in technology adoption, supply chain strategies, and regional policy responses. Scenario mapping was used to explore potential outcomes of tariff shifts and reimbursement changes, while sensitivity analyses tested the resilience of strategic recommendations under different operational constraints. Quality assurance included peer review by clinical and commercial experts to confirm factual accuracy and relevance. This mixed-methods approach ensures that conclusions are grounded in practitioner experience and validated against objective documentary evidence.

Concise synthesis of strategic imperatives and stakeholder alignments required to scale clinically effective and operationally resilient peritoneal dialysis programs

In summary, peritoneal dialysis stands at an inflection point where technology, policy, and care-delivery preferences intersect to create both significant opportunities and operational challenges. Advances in automation and solution biocompatibility are making home-based therapy more feasible and clinically attractive, yet trade policy shifts and supply chain vulnerabilities necessitate proactive mitigation strategies. Stakeholders that align product development with service models, invest in clinical evidence, and adopt resilient sourcing practices will be best positioned to meet growing clinical demand while protecting margins.

As the clinical community continues to emphasize patient-centered, outpatient care models, the ability to demonstrate improved outcomes, cost-effectiveness, and operational reliability will determine which solutions gain broad adoption. Therefore, collaboration across manufacturers, providers, payers, and regulators is essential to enable scalable, accessible, and sustainable peritoneal dialysis programs. The conclusion reinforces the imperative for strategic agility, clinical rigor, and stakeholder alignment as the sector advances into the next phase of care transformation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peritoneal Dialysis Market, by Product Type

  • 8.1. Accessories
    • 8.1.1. Bags for PD solutions
    • 8.1.2. Drainage bags
    • 8.1.3. Peritoneal Dialysis Catheter Kit
    • 8.1.4. Transfer sets
  • 8.2. PD Machines
    • 8.2.1. Automated Peritoneal Dialysis Cycler
    • 8.2.2. Continuous Ambulatory Peritoneal Dialysis
  • 8.3. Peritoneal Solution
    • 8.3.1. Biocompatible solutions
    • 8.3.2. Glucose-based solutions
    • 8.3.3. Low-glucose solutions

9. Peritoneal Dialysis Market, by Therapeutic Area

  • 9.1. Acute Kidney Injury
  • 9.2. Chronic Kidney Disease
  • 9.3. Congestive Heart Failure

10. Peritoneal Dialysis Market, by Application

  • 10.1. Diabetic Nephropathy
  • 10.2. Glomerulonephritis
  • 10.3. Lupus Nephritis
  • 10.4. Polycystic Kidney Disease

11. Peritoneal Dialysis Market, by End User

  • 11.1. Dialysis Centers
  • 11.2. Home Healthcare
  • 11.3. Hospitals

12. Peritoneal Dialysis Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Peritoneal Dialysis Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Peritoneal Dialysis Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Peritoneal Dialysis Market

16. China Peritoneal Dialysis Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Advin Health Care
  • 17.6. Angiplast Pvt. Ltd.
  • 17.7. B. Braun Medical Ltd
  • 17.8. Baxter International, Inc.
  • 17.9. Becton, Dickinson and Company
  • 17.10. Cook Group Incorporated
  • 17.11. Diaverum AB by M42
  • 17.12. Fresenius Medical Care AG
  • 17.13. Huaren Pharmaceutical Co., Ltd.
  • 17.14. JDmeditech
  • 17.15. JMS Co., Ltd.
  • 17.16. Medionics International Inc.
  • 17.17. Mitra Industries
  • 17.18. Mozarc Medical
  • 17.19. Opterion Health AG
  • 17.20. PFM Medical, Inc.
  • 17.21. Renax Biomedical Technology Co., Ltd.
  • 17.22. Renfrew Group International
  • 17.23. Romsons Prime Private limited
  • 17.24. Terumo Corporation
  • 17.25. Toray Industries, Inc.
  • 17.26. Vivance

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERITONEAL DIALYSIS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERITONEAL DIALYSIS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY BAGS FOR PD SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY BAGS FOR PD SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY BAGS FOR PD SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DRAINAGE BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DRAINAGE BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DRAINAGE BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS CATHETER KIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS CATHETER KIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS CATHETER KIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY TRANSFER SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY TRANSFER SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY TRANSFER SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS CYCLER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS CYCLER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS CYCLER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY BIOCOMPATIBLE SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY BIOCOMPATIBLE SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY BIOCOMPATIBLE SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GLUCOSE-BASED SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GLUCOSE-BASED SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GLUCOSE-BASED SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY LOW-GLUCOSE SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY LOW-GLUCOSE SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY LOW-GLUCOSE SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY ACUTE KIDNEY INJURY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY ACUTE KIDNEY INJURY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY ACUTE KIDNEY INJURY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DIABETIC NEPHROPATHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DIABETIC NEPHROPATHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DIABETIC NEPHROPATHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GLOMERULONEPHRITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GLOMERULONEPHRITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GLOMERULONEPHRITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY LUPUS NEPHRITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY LUPUS NEPHRITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY LUPUS NEPHRITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY POLYCYSTIC KIDNEY DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY POLYCYSTIC KIDNEY DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY POLYCYSTIC KIDNEY DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. GCC PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GCC PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. GCC PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 152. GCC PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2032 (USD MILLION)
  • TABLE 153. GCC PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 154. GCC PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 155. GCC PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. GCC PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. G7 PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. G7 PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. G7 PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 176. G7 PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2032 (USD MILLION)
  • TABLE 177. G7 PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 178. G7 PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 179. G7 PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. G7 PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. NATO PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. NATO PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. NATO PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 184. NATO PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2032 (USD MILLION)
  • TABLE 185. NATO PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 186. NATO PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 187. NATO PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. NATO PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA PERITONEAL DIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA PERITONEAL DIALYSIS MARKET SIZE, BY PD MACHINES, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA PERITONEAL DIALYSIS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA PERITONEAL DIALYSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)